These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 1491243)

  • 1. Early diagnosis in Parkinson's disease.
    Przuntek H
    J Neural Transm Suppl; 1992; 38():105-14. PubMed ID: 1491243
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preclinical (premotor) Parkinson's disease.
    Wolters EC; Francot C; Bergmans P; Winogrodzka A; Booij J; Berendse HW; Stoof JC
    J Neurol; 2000 Apr; 247 Suppl 2():II103-9. PubMed ID: 10991655
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identifying prodromal Parkinson's disease: pre-motor disorders in Parkinson's disease.
    Postuma RB; Aarsland D; Barone P; Burn DJ; Hawkes CH; Oertel W; Ziemssen T
    Mov Disord; 2012 Apr; 27(5):617-26. PubMed ID: 22508280
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early, nondisabling Parkinson's disease: weighing the options for initial therapy.
    Silver DE
    Neurol Clin; 2008 Aug; 26(3 Suppl):S1-13, v. PubMed ID: 18774439
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biomarkers for Parkinson's [corrected] disease: tools to assess Parkinson's disease onset and progression.
    Marek K; Jennings D; Tamagnan G; Seibyl J
    Ann Neurol; 2008 Dec; 64 Suppl 2():S111-21. PubMed ID: 19127587
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Nuclear medicine imaging in neurodegenerative dementias].
    Gratz S; Hahn U; Kaiser JW; Jarnig M; Schwarz J; Förstl H
    Dtsch Med Wochenschr; 2008 May; 133 Suppl 1():S5-7. PubMed ID: 18437639
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biomarkers for Parkinson's disease.
    Sherer TB
    Sci Transl Med; 2011 Apr; 3(79):79ps14. PubMed ID: 21508309
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biomarkers for the early detection of Parkinson's and Alzheimer's disease.
    Berg D
    Neurodegener Dis; 2008; 5(3-4):133-6. PubMed ID: 18322370
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early detection of Parkinson's disease: unmet needs.
    Gerlach M; Hendrich A; Hueber R; Jost W; Winkler J; Woitalla D; Riederer P
    Neurodegener Dis; 2008; 5(3-4):137-9. PubMed ID: 18322371
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Presymptomatic detection of Parkinson's disease.
    Jenner P
    J Neural Transm Suppl; 1993; 40():23-36. PubMed ID: 8294898
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The search for biomarkers in Parkinson's disease: a critical review.
    Antoniades CA; Barker RA
    Expert Rev Neurother; 2008 Dec; 8(12):1841-52. PubMed ID: 19086880
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of Parkinson's disease biomarkers.
    Prakash KM; Tan EK
    Expert Rev Neurother; 2010 Dec; 10(12):1811-25. PubMed ID: 21091313
    [TBL] [Abstract][Full Text] [Related]  

  • 13. International study on the psychometric attributes of the non-motor symptoms scale in Parkinson disease.
    Martinez-Martin P; Rodriguez-Blazquez C; Abe K; Bhattacharyya KB; Bloem BR; Carod-Artal FJ; Prakash R; Esselink RA; Falup-Pecurariu C; Gallardo M; Mir P; Naidu Y; Nicoletti A; Sethi K; Tsuboi Y; van Hilten JJ; Visser M; Zappia M; Chaudhuri KR
    Neurology; 2009 Nov; 73(19):1584-91. PubMed ID: 19901251
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnostic markers for Parkinson's disease.
    Chahine LM; Stern MB
    Curr Opin Neurol; 2011 Aug; 24(4):309-17. PubMed ID: 21464716
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diffusion-weighted brain imaging study of patients with clinical diagnosis of corticobasal degeneration, progressive supranuclear palsy and Parkinson's disease.
    Rizzo G; Martinelli P; Manners D; Scaglione C; Tonon C; Cortelli P; Malucelli E; Capellari S; Testa C; Parchi P; Montagna P; Barbiroli B; Lodi R
    Brain; 2008 Oct; 131(Pt 10):2690-700. PubMed ID: 18819991
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cognitive impairment in Parkinson's disease: tools for diagnosis and assessment.
    Kulisevsky J; Pagonabarraga J
    Mov Disord; 2009 Jun; 24(8):1103-10. PubMed ID: 19353727
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preclinical biomarkers of Parkinson disease.
    Wu Y; Le W; Jankovic J
    Arch Neurol; 2011 Jan; 68(1):22-30. PubMed ID: 21220674
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The status of imaging methods for the treatment of patients with Parkinson's syndrome].
    Schwarz J; Gratz S; Hahn U; Förstl H; Jarnig M
    Dtsch Med Wochenschr; 2008 May; 133 Suppl 1():S8-10. PubMed ID: 18437640
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuroimaging of nonmotor features of Parkinson's disease.
    Deblieck C; Wu AD
    Rev Neurol Dis; 2008; 5(3):125-33. PubMed ID: 18838952
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Imaging end points for monitoring neuroprotection in Parkinson's disease.
    Brooks DJ
    Ann Neurol; 2003; 53 Suppl 3():S110-8; discussion S118-9. PubMed ID: 12666103
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.